• Publications
  • Influence
Biocultural approaches to well-being and sustainability indicators across scales
It is argued that biocultural approaches, in combination with methods for synthesizing across evidence from multiple sources, are critical to developing metrics that facilitate linkages across scales and dimensions that help bridge the divide between ecosystems and human well-being.
On farm conservation of neglected and underutilized species: status, trends and novel approaches to cope with climate change. Proceedings of an international conference, Frankfurt, Germany, 14-16
This publication is the result of the International Conference held in Frankfurt, Germany 14-16 June 2011 organized in the framework of an International UN Project funded by IFAD “Reinforcing the
Rifamycin SV. A review.
Half-life of rifampicin after repeated administration of different doses in humans.
The threshold dose appears to be between 12 and 16 mg/kg in patients with normal liver function and interference between rifampicin and bilirubin does not appear dose-related and decreases during repeated administration.
Studies on blood serum levels of rifampicin in patients with normal and impaired liver function.
Patients with normal liver function present a dose-related change in the kinetics of rifampicin. The drug interferes with serum bilirubin levels. Interference with serum bilirubin levels practically d
Rifampicin in Free Combination with Other Antimicrobial Drugs in Non-Tb Infections (Part 1 of 2)
A review of the published literature has allowed the identification of a number of non-tubercular indications where rifampicin (trade mark Ciba-Geigy: Rimactane>) has been successfully used in
Culturally grounded indicators of resilience in social-ecological systems
Measuring progress toward sustainability goals is a multifaceted task. International, regional, and national organizations and agencies seek to promote resilience and capacity for adaptation at local
Parenteral rifampicin in tuberculous and severe non-mycobacterial infections. Clinical data on 237 patients.
Taking into account the severe, life-threatening infections reported, the results suggest that i.v. rifampicin is useful and in some critically ill patients even life-saving, although there seems to be the possibility that thrombophlebitis might develop if treatment is continued over 30 days.